These results indicate that MCT4 inhibition impedes the induction of angiogenesis, another crucial hallmark of tumor malignancy, in F98 glioma cells in vitro as well as in an ex vivo slice culture model, which more closely reflects the in vivo situation. Here, SLC16A3 is linked to glioma.